Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma.

Yuwu Liu1,2,3, Chang Wu4, Ying Wang1,2, Sailan Wen1,2, Junpu Wang1,2, Zhihong Chen1,2, Qiongqiong He1,2, and Deyun Feng1,2* Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China Department of Pathology, School of Basic Medical Sciences, Central South University, Changsha 410013, China Department of Morphology, The Institute of Advanced Occupation Technology, Xinjiang Medical University, Urumqi 830011, China Department of Pathology, Shenzhen Sixth People’s Hospital (Nanshan Hospital), Shenzhen 518052, China *Correspondence address: Tel/Fax: þ86-731-82650410; E-mail: [email protected]